![Michael Creese Operations Director, Chemistry, Medical Device Testing](https://azb4fstg-cdn-endpoint.azureedge.net/mediacontainer/medialibraries/smithersb4f/experts/mike-creese_1.png?ext=.png)
Michael
Creese
Operations Director, Chemistry, Medical Device Testing
United Kingdom
Contact MichaelSmithers wants to offer its customers the latest cutting-edge technology for targeted and non-targeted screening analysis and structural elucidation. The Vion is one of the most recent instruments developed by leading mass spectrometer manufacturer, Waters. It offers features which facilitate high confidence structural assignments, including:
Smithers now offers both LC-HRAMS screening and bespoke structural elucidation services. These include:
LC-HRAMS has revolutionized mass spectrometry within Smithers. It has led to high certainty in library matches and also enabled elemental formula to be proposed for the majority of unknown compounds. What this means for the customer is that when we provide screening analysis using LC-MS there are significantly fewer instances where we are unable to provide identification or any other qualitative information about the substances we detected.
Find out more about our chromatography and spectrometry test capabilties at Smithers.